Oral exclusive enteral nutrition for induction of clinical remission, mucosal healing, and improvement of nutritional status and growth velocity in children with active Crohn’s disease – a prospective multicentre trial

Ítems similars

• Efficacy of Adalimumab in Korean Patients with Crohn’s Disease
  Publicat: (2016-03-01)
• Distinct alterations of fecal microbiota refer to the efficacy of adalimumab in Crohn’s disease
  per: Liang Chen, et al.
  Publicat: (2022-08-01)
• Adalimumab and azathioprine in the prevention of postoperative crohn’s disease recurrence
  per: A. V. Poletova, et al.
  Publicat: (2020-10-01)
• Oral exclusive enteral nutrition for induction of clinical remission, mucosal healing, and improvement of nutritional status and growth velocity in children with active Crohn’s disease – a prospective multicentre trial
  per: Małgorzata Matuszczyk, et al.
  Publicat: (2021-12-01)
• Crohn’s Disease Associated Pyoderma Gangrenosum Treated with Adalimumab
  per: Despoina Kakagia, et al.
  Publicat: (2012-03-01)